LUCD Lucid Diagnostics Inc.
Nasdaq · SEC CIK 1799011 · EDGAR
- Bought, last 12 months
- $245.3K 1 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 62 since 2021-10-20, latest 2026-05-21 16:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Matheis Dennis | Dir | $245.3K | — |
| Gordon Michael Adam | GC, Sec | — | — |
| O'Neil Shaun | Pres, COO | — | — |
| White Debra | Dir | — | — |
| Lapidus Stanley | Dir | — | — |
| Cox James L | Dir | — | — |
| Sparks Ronald M | Dir | — | — |
| Aklog Lishan | CEO, Dir | — | — |
| SOKOLOV JACQUE J | Dir | — | — |
| MCGRATH DENNIS M | CFO | — | — |
Transactions 41
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 16:20 | 2026-05-20 | LUCD | Matheis Dennis | Dir | P - Purchase | $1.00 | +245.0K | 1.03M | +31% | +$245.3K | |
| 2026-02-24 | 2026-02-20 | LUCD | Matheis Dennis | Dir | A - Grant | $0.00 | +123.0K | 788.4K | +18% | $0 | |
| 2026-02-24 | 2026-02-20 | LUCD | Gordon Michael Adam | GC, Sec | A - Grant | $0.00 | +300.0K | 1.00M | +43% | $0 | |
| 2026-02-24 | 2026-02-20 | LUCD | Lapidus Stanley | Dir | A - Grant | $0.00 | +123.0K | 337.4K | +57% | $0 | |
| 2026-02-24 | 2026-02-20 | LUCD | O'Neil Shaun | Pres, COO | A - Grant | $0.00 | +620.0K | 1.45M | +75% | $0 | |
| 2026-02-24 | 2026-02-20 | LUCD | SOKOLOV JACQUE J | Dir | A - Grant | $0.00 | +123.0K | 320.5K | +62% | $0 | |
| 2026-02-24 | 2026-02-20 | LUCD | MCGRATH DENNIS M | CFO | A - Grant | $0.00 | +470.0K | 1.81M | +35% | $0 | |
| 2026-02-24 | 2026-02-20 | LUCD | White Debra | Dir | A - Grant | $0.00 | +123.0K | 235.8K | +109% | $0 | |
| 2026-02-24 | 2026-02-20 | LUCD | PALUMBO JOHN R | Dir | A - Grant | $0.00 | +123.0K | 338.0K | +57% | $0 | |
| 2026-02-24 | 2026-02-20 | LUCD | Aklog Lishan | CEO, Dir | A - Grant | $0.00 | +2.17M | 3.64M | +148% | $0 | |
| 2026-02-24 | 2026-02-20 | LUCD | Cox James L | Dir | A - Grant | $0.00 | +123.0K | 405.1K | +44% | $0 | |
| 2026-02-24 | 2026-02-20 | LUCD | Sparks Ronald M | Dir | A - Grant | $0.00 | +123.0K | 320.5K | +62% | $0 | |
| 2025-08-22 | 2025-08-20 | LUCD | Matheis Dennis | Dir | P - Purchase | $1.02 | +100.0K | 665.4K | +18% | +$102.0K | |
| MA | 2025-05-23 | 2025-05-20+ | LUCD | Matheis Dennis | Dir | P - Purchase | $1.31 | +350.0K | 565.4K | +162% | +$458.3K |
| M | 2025-05-22 | 2025-05-20+ | LUCD | Matheis Dennis | Dir | P - Purchase | $1.31 | +350.0K | 187.1K | New | +$458.3K |
| 2025-02-21 | 2025-02-20 | LUCD | Lapidus Stanley | Dir | A - Grant | $0.00 | +112.8K | 214.4K | +111% | $0 | |
| 2025-02-21 | 2025-02-20 | LUCD | SOKOLOV JACQUE J | Dir | A - Grant | $0.00 | +112.8K | 197.5K | +133% | $0 | |
| 2025-02-21 | 2025-02-20 | LUCD | Aklog Lishan | CEO, Dir | A - Grant | $0.00 | +300.0K | 1.47M | +26% | $0 | |
| 2025-02-21 | 2025-02-20 | LUCD | Sparks Ronald M | Dir | A - Grant | $0.00 | +112.8K | 197.5K | +133% | $0 | |
| 2025-02-21 | 2025-02-20 | LUCD | Matheis Dennis | Dir | A - Grant | $0.00 | +112.8K | 162.7K | +226% | $0 | |
| 2025-02-21 | 2025-02-20 | LUCD | Gordon Michael Adam | GC, Sec | A - Grant | $0.00 | +300.0K | 700.0K | +75% | $0 | |
| 2025-02-21 | 2025-02-20 | LUCD | MCGRATH DENNIS M | CFO | A - Grant | $0.00 | +300.0K | 1.34M | +29% | $0 | |
| 2025-02-21 | 2025-02-20 | LUCD | White Debra | Dir | A - Grant | $0.00 | +112.8K | 112.8K | New | $0 | |
| 2025-02-21 | 2025-02-20 | LUCD | Cox James L | Dir | A - Grant | $0.00 | +112.8K | 282.1K | +67% | $0 | |
| 2025-02-21 | 2025-02-20 | LUCD | O'Neil Shaun | Pres, COO | A - Grant | $0.00 | +300.0K | 826.8K | +57% | $0 | |
| 2024-05-08 | 2024-05-07 | LUCD | MCGRATH DENNIS M | CFO | A - Grant | $0.00 | +400.0K | 1.04M | +62% | $0 | |
| 2024-05-08 | 2024-05-07 | LUCD | Gordon Michael Adam | GC, Sec | A - Grant | $0.00 | +400.0K | 400.0K | New | $0 | |
| 2024-05-08 | 2024-05-07 | LUCD | Aklog Lishan | CEO, Dir | A - Grant | $0.00 | +400.0K | 1.17M | +52% | $0 | |
| 2024-05-08 | 2024-05-07 | LUCD | O'Neil Shaun | Pres, COO | A - Grant | $0.00 | +400.0K | 526.8K | +316% | $0 | |
| 2024-02-20 | 2024-02-15 | LUCD | PAVmed Inc. | 10% | J - Other | — | -3.33M | 31.30M | -10% | — | |
| 2024-01-30 | 2024-01-26 | LUCD | PAVmed Inc. | 10% | J - Other | $1.40 | +3.33M | 34.63M | +11% | +$4.66M | |
| MA | 2023-09-27 | 2023-09-20+ | LUCD | Lapidus Stanley | Dir | S - Sale | $1.45 | -3,917 | 132.1K | -3% | -$5,675 |
| M | 2023-09-27 | 2023-09-25+ | LUCD | Lapidus Stanley | Dir | S - Sale | $1.45 | -29.9K | 101.6K | -23% | -$43.4K |
| M | 2023-09-22 | 2023-09-20+ | LUCD | Lapidus Stanley | Dir | S - Sale | $1.45 | -3,917 | 131.5K | -3% | -$5,675 |
| MA | 2023-04-13 | 2022-11-30 | LUCD | PAVmed Inc. | 10% | J - Other | $1.92 | +3.38M | 31.30M | +12% | +$6.48M |
| M | 2022-12-02 | 2022-11-30 | LUCD | PAVmed Inc. | 10% | J - Other | $1.92 | +3.38M | 40.67M | +9% | +$6.48M |
| M | 2022-09-22 | 2022-09-20 | LUCD | Lapidus Stanley | Dir | S - Sale | $1.71 | -33.9K | 135.5K | -20% | -$57.7K |
| 2022-01-10 | 2022-01-07 | LUCD | MCGRATH DENNIS M | CFO | A - Grant | $0.00 | +60.0K | 624.4K | +11% | $0 | |
| 2022-01-10 | 2022-01-07 | LUCD | Aklog Lishan | CEO, Dir | A - Grant | $0.00 | +60.0K | 624.4K | +11% | $0 | |
| 2021-10-20 | 2021-10-18 | LUCD | Sparks Ronald M | Dir | A - Grant | $0.00 | +84.7K | 84.7K | New | $0 | |
| 2021-10-20 | 2021-10-18 | LUCD | PAVmed Inc. | 10% | P - Purchase | $14.00 | +571.4K | 27.93M | +2% | +$8.00M |
Purchase Sale Sale after option exercise All abbreviations